1-3 of 3
Christophe Hennequin
Close
Sort by
Journal Articles

Impact of Pre-Transplantation and Post-Transplantation Positron Emission Tomography (PET) Using 18-Fluorodeoxyglucose in Lymphoma Patients Treated with Autologous Stem Cell Transplantation.

Nicolas Mounier, MD, Christian Gisselbrecht, MD, Jean-Emmanuel Filmont, MD, Xavier Cuenca, MD, Laure Deville, Pharm D, Pauline Brice, MD, Josette Briere, MD, Eric De Kerviler, MD, Jerome Larghero, Pharm D, Marjan Ertault, MD, Christophe Hennequin, MD, Jean-Luc Moretti, MD
Journal: Blood
Blood (2006) 108 (11): 3055.
https://doi.org/10.1182/blood.V108.11.3055.3055
Published: 2006
Journal Articles

Prognostic Factors in Localized Hodgkin’s Lymphoma: How To Define Intermediate/Unfavourable Disease?.

Christian Gisselbrecht, Nicolas Mounier, Olivier Casanovas, O. Reman, Catherine Sebban, Marine Divine, Pauline Brice, Josette Briere, Christophe Hennequin, Pierre Feugier, Christophe Ferme
Journal: Blood
Blood (2004) 104 (11): 3122.
https://doi.org/10.1182/blood.V104.11.3122.3122
Published: 2004
Journal Articles

Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the Groupe d'études des Lymphomes de l'Adulte H89 trial

Christophe Fermé, Catherine Sebban, Christophe Hennequin, Marine Diviné, Pierre Lederlin, Jean Gabarre, Augustin Ferrant, Denis Caillot, Dominique Bordessoule, Pauline Brice, Isabelle Moullet, Françoise Berger, Eric Lepage
Journal: Blood
Blood (2000) 95 (7): 2246–2252.
https://doi.org/10.1182/blood.V95.7.2246
Published: 2000